Three genes — APP, PSEN1 and PSEN2 — cause early-onset familial Alzheimer's that can start from the 30s to mid-60s. Dominant variants in C9orf72, GRN and MAPT cause most inherited frontotemporal dementia, while an expanded HTT repeat causes Huntington's disease. Cognitive decline means a lasting drop in memory, thinking, language, judgment or behavior that limits daily life. In younger adults, one altered copy of these dominant genes can drive disease, while APOE e4 only raises risk.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Which Alzheimer's genes affect younger adults?
- What causes inherited frontotemporal decline?
- How does the Huntington's gene harm early thinking?
- Does APOE e4 explain decline in young adults?
Which Alzheimer's genes affect younger adults?
Variants in APP, PSEN1 and PSEN2 cause early-onset familial Alzheimer's in an autosomal-dominant pattern. That means one altered copy can cause disease, with symptoms from the 30s to mid-60s, according to the U.S. National Library of Medicine in its MedlinePlus Alzheimer's genetics page.
The National Institute on Aging studies these PSEN1, PSEN2 and APP mutations to track biological changes. The goal is earlier diagnosis and clearer tracking of progression. A strong early-onset family pattern points toward this inherited form.
What causes inherited frontotemporal decline?
Most genetic frontotemporal dementia comes from dominantly inherited variants in C9orf72, GRN and MAPT. The NHS National Genomics Education Programme describes this pattern in its GeNotes frontotemporal dementia guide.
This form often begins around age 58 and rarely begins before 40. It can change behavior, personality and language, and it can impair motor function. Behavior change may look like apathy, disinhibition or loss of empathy, while language change may show as word loss or reduced speech.
How does the Huntington's gene harm early thinking?
Huntington's disease comes from an expanded CAG repeat in the HTT huntingtin gene. Early signs often include cognitive or psychiatric symptoms plus clumsiness or balance problems, according to the National Institute of Neurological Disorders and Stroke in its Huntington's disease information page. Young carriers can show weaker executive function as early as age 18.
That affects decision-making, emotion regulation and impulse control, often long before motor symptoms, Vanderbilt University Medical Center reported from a Journal of Neurology, Neurosurgery and Psychiatry study. The HD-Young Adult Study followed 43 gene-expanded and 28 control young adults about 4.7 years apart. Carriers showed poorer sustained attention with altered brain connectivity, without measurable further decline over that interval, UCL researchers reported.
Does APOE e4 explain decline in young adults?
APOE e4 is a risk-factor gene, not a deterministic cause. Many carriers never develop dementia and many patients lack e4, so testing is not routinely used for diagnosis or prediction, the National Institute on Aging Alzheimer's Disease Genetics Fact Sheet states. A study of 1,000 healthy adults ages 18-35 found no detectable difference between APOE e3/e4 carriers and e3/e3 carriers on spatial navigation, working memory, processing speed or executive function, reported in Scientific Reports in its APOE young-adult cognition study.
The comparison included 88 e3/e4 carriers and 327 e3/e3 carriers. Family history matters more than APOE alone for younger adults. Practical next steps include:.
- write down relatives with dementia, movement disorder or early behavior change, with ages at onset
- bring new memory, language, behavior or coordination changes to primary care promptly
- ask about referral to neurology or genetics when early-onset or Huntington's patterns run in the family





